Tortoise Capital Advisors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-10
Closed -$1K 127
2019
Q2
$1K Hold
10
﹤0.01% 138
2019
Q1
$1K Hold
10
﹤0.01% 134
2018
Q4
$1K Hold
10
﹤0.01% 135
2018
Q3
$1K Hold
10
﹤0.01% 144
2018
Q2
$1K Buy
+10
New +$1.22K ﹤0.01% 143
2018
Q1
Sell
-10
Closed -$1K 179
2017
Q4
$1K Hold
10
﹤0.01% 144
2017
Q3
$1K Hold
10
﹤0.01% 137
2017
Q2
$1K Hold
10
﹤0.01% 138
2017
Q1
$1K Hold
10
﹤0.01% 138
2016
Q4
$1K Hold
10
﹤0.01% 143
2016
Q3
$1K Hold
10
﹤0.01% 137
2016
Q2
$1K Hold
10
﹤0.01% 134
2016
Q1
$1K Hold
10
﹤0.01% 133
2015
Q4
$1K Hold
10
﹤0.01% 129
2015
Q3
$1K Buy
10
+2
+25% +$218 ﹤0.01% 134
2015
Q2
$1K Hold
8
﹤0.01% 134
2015
Q1
$1K Buy
+8
New +$852 ﹤0.01% 126

Other funds holding CLB

Tortoise Capital Advisors's CLB Position: Q3 2019 in Review

Tortoise Capital Advisors sold out of Core Laboratories (CLB) in Q3 2019, closing a stake of 10 shares — an estimated $1K sold.

Tortoise Capital Advisors first reported a position in CLB in Q1 2015 and held it in 17 quarters. The position peaked at $1K in Q2 2019. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

  • Tortoise Capital Advisors reported no remaining Core Laboratories position as of Q3 2019 after selling out during the quarter.
  • Tortoise Capital Advisors sold 10 Core Laboratories shares in Q3 2019, an estimated $1K.
  • Tortoise Capital Advisors first reported a position in Core Laboratories in Q1 2015 and held it in 17 quarters.
  • Tortoise Capital Advisors's Core Laboratories position peaked at $1K in Q2 2019.
  • 274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on Tortoise Capital Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.